JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Susan Smith
Mark F. O'Brien
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hogan, P.
Right arrow Articles by O'Brien, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hogan, P.
Right arrow Articles by O'Brien, M. F.

J Thorac Cardiovasc Surg 1996;112:1260-1267
© 1996 Mosby, Inc.


SURGERY FOR ACQUIRED HEART DISEASE

HUMAN AORTIC VALVE ALLOGRAFTS ELICIT A DONOR-SPECIFIC IMMUNE RESPONSE

Patrick Hogan, FRACP, FRCPAa, Lynette Duplock, MSca, Marjorie Green, PhDb, Susan Smith, BScc, Kenneth L. Gall, BAppScc, Ian H. Frazer, FRCP, FRCPAa, Mark F. O'Brien, FRCS, FRACSc

Supported by The Prince Charles Hospital Foundation.

Received for publication May 6, 1996 Revisions requested June 11, 1996; revisions received July 1, 1996 Accepted for publication July 1, 1996. Address for reprints: M. O'Brien, MD, Department of Cardiac Surgery, The Prince Charles Hospital, Rode Road, Chermside 4032. Brisbane, Australia.

Abstract

Objective: The nature and magnitude of the immunologic response to implantation of human cryopreserved aortic valve allografts was investigated. Methods: Twenty aortic valve allograft recipients were investigated for donor-specific antibody and T-cell–mediated responses with serial flow cytometric and microlymphocytotoxic crossmatch assays and one-way mixed lymphocyte cultures. Results: Donor-specific immunoglobulin G antibodies to class I and II human leukocyte antigens were first detected in the serum of all aortic valve allograft recipients at 30 days after implantation and persisted in substantial amounts in all but one of the recipients at day 365. Recipient T-cell alloreactivity toward donor lymphocytes was significantly increased at day 30 compared with levels before and 10 days after operation. Conclusions: Cryopreserved aortic valve allografts elicit a substantial allogeneic response in recipients. This alloreactivity may contribute to the observed morphologic changes in aortic valve allografts and eventual long-term deterioration of allograft function. (J THORAC CARDIOVASC SURG 1996;112:1260-7)




This article has been cited by other articles:


Home page
Eur Heart JHome page
E. Troost, B. Meyns, W. Daenen, F. Van de Werf, M. Gewillig, K. Van Deyk, P. Moons, and W. Budts
Homograft survival after tetralogy of Fallot repair: determinants of accelerated homograft degeneration
Eur. Heart J., October 2, 2007; 28(20): 2503 - 2509.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. J. Lehr, G. R. Rayat, L. S. Desai, J. Y. Coe, G. S. Korbutt, and D. B. Ross
Inbred or outbred? An evaluation of the functional allogenicity of farm sheep used in cardiac valve studies.
J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1156 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
B. Meyns, R. Jashari, M. Gewillig, L. Mertens, A. Komarek, E. Lesaffre, W. Budts, and W. Daenen
Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first
Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 211 - 216.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Rieder, G. Seebacher, M.-T. Kasimir, E. Eichmair, B. Winter, B. Dekan, E. Wolner, P. Simon, and G. Weigel
Tissue Engineering of Heart Valves: Decellularized Porcine and Human Valve Scaffolds Differ Importantly in Residual Potential to Attract Monocytic Cells
Circulation, May 31, 2005; 111(21): 2792 - 2797.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Sayk, I. Bos, U. Schubert, T. Wedel, and H.-H. Sievers
Histopathologic Findings in a Novel Decellularized Pulmonary Homograft: An Autopsy Study
Ann. Thorac. Surg., May 1, 2005; 79(5): 1755 - 1758.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. R. Meyer, P. M. Campbell, J. M. Rutledge, A. M. Halpin, L. E. Hawkins, J. R.T. Lakey, I. M. Rebeyka, and D. B. Ross
Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation
Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 554 - 560.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. W. Grauss, M. G. Hazekamp, F. Oppenhuizen, C. J. van Munsteren, A. C. Gittenberger-de Groot, and M. C. DeRuiter
Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods
Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 566 - 571.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Ketchedjian, A. L. Jones, P. Krueger, E. Robinson, K. Crouch, L. Wolfinbarger Jr, and R. Hopkins
Recellularization of Decellularized Allograft Scaffolds in Ovine Great Vessel Reconstructions
Ann. Thorac. Surg., March 1, 2005; 79(3): 888 - 896.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Ketchedjian, P. Kreuger, H. Lukoff, E. Robinson, A. Linthurst-Jones, K. Crouch, L. Wolfinbarger, and R. Hopkins
Ovine panel reactive antibody assay of HLA responsivity to allograft bioengineered vascular scaffolds
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 159 - 166.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Pompilio, G. Polvani, G. Piccolo, A. Guarino, A. Nocco, A. Innocente, M. Porqueddu, L. Dainese, F. Veglia, A. Sala, et al.
Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: Implications with valve dysfunction
Ann. Thorac. Surg., August 1, 2004; 78(2): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. W. Grauss, M. G. Hazekamp, S. van Vliet, A. C. Gittenberger-de Groot, and M. C. DeRuiter
Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. G. Hogan and M. F. O'Brien
Improving the allograft valve: does the immune response matter?
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1251 - 1253.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Mathieu, J. C. Roussel, F. Dagenais, and I. Anegon
Cartilaginous metaplasia and calcification in aortic allograft is associated with transforming growth factor {beta}1 expression
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1449 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. Wells, M. Malas, C. J. Baker, S. M. Quardt, and M. L. Barr
Depopulated vena caval homograft: a new venous conduit
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 498 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. F. Baskett, M. A. Nanton, A. E. Warren, and D. B. Ross
Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 232 - 238.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Cebotari, H. Mertsching, K. Kallenbach, S. Kostin, O. Repin, A. Batrinac, C. Kleczka, A. Ciubotaru, and A. Haverich
Construction of Autologous Human Heart Valves Based on an Acellular Allograft Matrix
Circulation, September 24, 2002; 106(12_suppl_1): I-63 - I-68.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.F. M. Bechtel, C. Bartels, C. Schmidtke, W. Skibba, M. Muller-Steinhardt, H. Kluter, and H.-H. Sievers
Does Histocompatibility Affect Homograft Valve Function After the Ross Procedure?
Circulation, September 18, 2001; 104(90001): I-25 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J.-F. Legare, D. B. Ross, T. B. Issekutz, W. Ruigrok, K. Creaser, G. M. Hirsch, and T. D.G. Lee
Prevention of allograft heart valve failure in a rat model
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 310 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Batten, A. M. McCormack, M. L. Rose, and M. H. Yacoub
Valve interstitial cells induce donor-specific T-cell anergy
J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 129 - 135.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J.F. M. Bechtel, C. Bartels, C. Schmidtke, W. Skibba, M. Muller-Steinhardt, H. Kluter, and H.-H. Sievers
Anti-HLA class I antibodies and pulmonary homograft function after the Ross procedure
Ann. Thorac. Surg., June 1, 2001; 71(6): 2003 - 2007.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. B.S. Oei, M. J.P. Welters, C. J. Knoop, L. M.B. Vaessen, A. P.A. Stegmann, W. Weimar, and A. J.J.C. Bogers
Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients
Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. F. Legare, T. D.G. Lee, K. Creaser, and D. B. Ross
T lymphocytes mediate leaflet destruction and allograft aortic valve failure in rats
Ann. Thorac. Surg., October 1, 2000; 70(4): 1238 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Niwaya, C. J. Knott-Craig, M. M. Lane, K. Chandrasekaren, E. D. Overholt, and R. C. Elkins
CRYOPRESERVED HOMOGRAFT VALVES IN THE PULMONARY POSITION: RISK ANALYSIS FOR INTERMEDIATE-TERM FAILURE
J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. M.E. Hoekstra, M. Witvliet, C. Y. Knoop, C. Wassenaar, A. J.J.C. Bogers, W. Weimar, and F. H.J. Claas
Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies
Ann. Thorac. Surg., December 1, 1998; 66(6): 2022 - 2026.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. N. Mitchell and F. J. Schoen
Aortic valves are antigenic but less so than myocardium
J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 532 - 533.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. N. Mitchell, R. A. Jonas, and F. J. Schoen
Pathology Of Explanted Cryopreserved Allograft Heart Valves: Comparison With Aortic Valves From Orthotopic Heart Transplants
J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Moustapha, D. B. Ross, B. Bittira, D. Van-Velzen, V. C. McAlister, C. L. Lannon, T. D. Lee, and S. D. A. Murphy
AORTIC VALVE GRAFTS IN THE RAT: EVIDENCE FOR REJECTION
J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 891 - 902.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The American Association for Thoracic Surgery.